{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:42:35Z","timestamp":1791420155733,"version":"4.3.3"},"reference-count":119,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"vor","delay-in-days":1450,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.bbadis.2009.10.017","type":"journal-article","created":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T05:41:10Z","timestamp":1258004470000},"page":"1178-1187","source":"Crossref","is-referenced-by-count":154,"title":["The role of 11\u03b2-hydroxysteroid dehydrogenase type 2 in human hypertension"],"prefix":"10.1016","volume":"1802","author":[{"given":"Paolo","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2009.10.017_bib1","first-page":"385","article-title":"Unusual steroid excretion in a child with low renin hypertension","volume":"6","author":"Werder","year":"1974","journal-title":"Res. Steroids"},{"key":"10.1016\/j.bbadis.2009.10.017_bib2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0009-9260(71)80050-8","article-title":"Retroperitoneal pneumography in the investigation of adrenal disease","volume":"22","author":"McLachlan","year":"1971","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib3","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1681\/ASN.2006111235","article-title":"Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess","volume":"18","author":"Atanasov","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1210\/jcem-44-5-924","article-title":"Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension","volume":"44","author":"New","year":"1977","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1210\/jcem-49-5-757","article-title":"A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol","volume":"49","author":"Ulick","year":"1979","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11906-007-0020-8","article-title":"Why are mineralocorticoid receptors so nonselective?","volume":"9","author":"Funder","year":"2007","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.bbadis.2009.10.017_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2009.10.017_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2009.10.017_bib9","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1073\/pnas.80.19.6056","article-title":"Renal mineralocorticoid receptors and hippocampal corticosterone- binding species have identical intrinsic steroid specificity","volume":"80","author":"Krozowski","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.bbadis.2009.10.017_bib10","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(88)90742-8","article-title":"Localisation of 11\u03b2-hydroxysteroid dehydrogenase\u2014tissue specific protector of the mineralocorticoid receptor","volume":"2","author":"Edwards","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2009.10.017_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2004.12.010","article-title":"RALES, EPHESUS and redox","volume":"93","author":"Funder","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib12","doi-asserted-by":"crossref","first-page":"18939","DOI":"10.1016\/S0021-9258(19)47248-7","article-title":"Cloning and expression of rat cDNA encoding corticosteroid 11\u03b2-dehydrogenase","volume":"264","author":"Agarwal","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.017_bib13","doi-asserted-by":"crossref","first-page":"16653","DOI":"10.1016\/S0021-9258(18)55351-5","article-title":"The human gene for 11\u03b2-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization","volume":"266","author":"Tannin","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.017_bib14","first-page":"970","article-title":"Tissue-specific distribution of the NAD(+)-dependent isoform of 11\u03b2-hydroxysteroid dehydrogenase","volume":"131","author":"Walker","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2009.10.017_bib15","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1016\/0303-7207(94)90176-7","article-title":"Cloning and tissue distribution of the human 11\u03b2-hydroxysteroid dehydrogenase type 2 enzyme","volume":"105","author":"Albiston","year":"1994","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/07435809509030455","article-title":"Cloning of cDNA encoding an NAD(+)-dependent isoform of 11\u03b2-hydroxysteroid dehydrogenase in sheep kidney","volume":"21","author":"Agarwal","year":"1995","journal-title":"Endocr. Res."},{"key":"10.1016\/j.bbadis.2009.10.017_bib17","doi-asserted-by":"crossref","first-page":"14924","DOI":"10.1073\/pnas.94.26.14924","article-title":"11\u03b2-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress","volume":"94","author":"Kotelevtsev","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2009.10.017_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0303-7207(00)00386-5","article-title":"Phenotypic analysis of mice bearing targeted deletions of 11\u03b2-hydroxysteroid dehydrogenases 1 and 2 genes","volume":"171","author":"Holmes","year":"2001","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib19","doi-asserted-by":"crossref","first-page":"41293","DOI":"10.1074\/jbc.M103676200","article-title":"Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11\u03b2-hydroxysteroid dehydrogenase type 1 null mice","volume":"276","author":"Morton","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.017_bib20","first-page":"E900","article-title":"Substrate and inhibitor specificity of the cloned human 11\u03b2-hydroxysteroid dehydrogenase type 2 isoform","volume":"270","author":"Ferrari","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib21","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1210\/endo.138.7.5232","article-title":"Oxoreductase and dehydrogenase activities of the human and rat 11\u03b2-hydroxysteroid dehydrogenase type 2 enzyme","volume":"138","author":"Li","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2009.10.017_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/endo-129-1-17","article-title":"11\u03b2-hydroxysteroid dehydrogenase activity in the renal target cells of aldosterone","volume":"129","author":"Naray-Fejes-Toth","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2009.10.017_bib23","first-page":"2203","article-title":"Immunohistochemical localization of the 11\u03b2-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta","volume":"80","author":"Krozowski","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib24","doi-asserted-by":"crossref","first-page":"28484","DOI":"10.1074\/jbc.M100374200","article-title":"The intracellular localization of the mineralocorticoid receptor is regulated by 11\u03b2-hydroxysteroid dehydrogenase type 2","volume":"276","author":"Odermatt","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.017_bib25","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1210\/endo.139.6.6036","article-title":"Extranuclear localization of endogenous 11\u03b2-hydroxysteroid dehydrogenase-2 in aldosterone target cells","volume":"139","author":"Naray-Fejes-Toth","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2009.10.017_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2265.1989.tb01259.x","article-title":"The kidney is the major site of cortisone production in man","volume":"31","author":"Whitworth","year":"1989","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.bbadis.2009.10.017_bib27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1210\/endo.130.1.1727721","article-title":"Localization of an 11\u03b2-hydroxysteroid dehydrogenase activity to the distal nephron. Evidence for the existence of two species of dehydrogenase in the rat kidney","volume":"130","author":"Mercer","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2009.10.017_bib28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0039-128X(96)00118-9","article-title":"Quantitation of cortisol and related 3-oxo-4-ene steroids in urine using gas chromatography\/mass spectrometry with stable isotope-labeled internal standards","volume":"61","author":"Palermo","year":"1996","journal-title":"Steroids"},{"key":"10.1016\/j.bbadis.2009.10.017_bib29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2265.1996.00853.x","article-title":"Urinary free cortisone and the assessment of 11\u03b2-hydroxysteroid dehydrogenase activity in man","volume":"45","author":"Palermo","year":"1996","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0960-0760(93)90132-G","article-title":"Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research","volume":"45","author":"Shackleton","year":"1993","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib31","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/hy1101.096112","article-title":"In vivo 11\u03b2HSD-2 activity: variability, salt-sensitivity, and effect of licorice","volume":"38","author":"Ferrari","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2009.10.017_bib32","first-page":"S25","article-title":"The role of the renin-angiotensin system in blood pressure regulation in normotensive animals and man","volume":"2","author":"Corvol","year":"1984","journal-title":"J. Hypertens. Suppl."},{"key":"10.1016\/j.bbadis.2009.10.017_bib33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/endo-85-2-381","article-title":"Effect of (K+) on the secretion of aldosterone","volume":"85","author":"Funder","year":"1969","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2009.10.017_bib34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0300-9629(87)90355-0","article-title":"Freshwater or marine origin of the vertebrates?","volume":"87","author":"Griffith","year":"1987","journal-title":"Comp. Biochem. Physiol. A"},{"key":"10.1016\/j.bbadis.2009.10.017_bib35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1159\/000168759","article-title":"A history of salt","volume":"14","author":"Cirillo","year":"1994","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib36","series-title":"Renal Physiology","author":"Smith","year":"1964"},{"key":"10.1016\/j.bbadis.2009.10.017_bib37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s394-001-8347-4","article-title":"Diet, evolution and aging\u2013the pathophysiologic effects of the post-agricultural inversion of the potassium-to-sodium and base-to-chloride ratios in the human diet","volume":"40","author":"Frassetto","year":"2001","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.bbadis.2009.10.017_bib38","first-page":"R3","article-title":"Structural organization of the renal medulla: comparative and functional aspects","volume":"241","author":"Kriz","year":"1981","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib39","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1210\/me.2005-0247","article-title":"The evolution of mineralocorticoid receptors","volume":"20","author":"Hu","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.2002.tb04415.x","article-title":"The pathophysiology of aldosterone in the cardiovascular system","volume":"970","author":"Rocha","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2009.10.017_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0083-6729(03)01004-5","article-title":"Forms of mineralocorticoid hypertension","volume":"66","author":"Ferrari","year":"2003","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.bbadis.2009.10.017_bib42","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1210\/jc.2001-011766","article-title":"Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk","volume":"87","author":"Tauchmanova","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib43","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1152\/ajplegacy.1969.217.5.1396","article-title":"Effects of corticosteroids on plasma angiotensinogen and renin activity","volume":"217","author":"Nasjletti","year":"1969","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib44","first-page":"1009","article-title":"Induction of angiotensinogen mRNA in hepatocytes by angiotensin II and glucocorticoids","volume":"10","author":"Klett","year":"1988","journal-title":"Clin. Exp. Hypertens. A"},{"key":"10.1016\/j.bbadis.2009.10.017_bib45","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/01.HYP.19.6.567","article-title":"Pressor responsiveness in corticosteroid-induced hypertension in humans","volume":"19","author":"Pirpiris","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2009.10.017_bib46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0039-128X(96)00013-X","article-title":"The 11\u03b2-hydroxysteroid dehydrogenase type II enzyme: biochemical consequences of the congenital R337C mutation","volume":"61","author":"Ferrari","year":"1996","journal-title":"Steroids"},{"key":"10.1016\/j.bbadis.2009.10.017_bib47","first-page":"3617","article-title":"11\u03b2-hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome","volume":"80","author":"Stewart","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib48","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJM199812103392414","article-title":"Cure of apparent mineralocorticoid excess by kidney transplantation","volume":"339","author":"Palermo","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2009.10.017_bib49","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1210\/jcem-72-5-1060","article-title":"Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor","volume":"72","author":"Montrella-Waybill","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib50","first-page":"S37","article-title":"Dose\u2013response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans","volume":"14","author":"Williamson","year":"1996","journal-title":"J. Hypertens. Suppl."},{"key":"10.1016\/j.bbadis.2009.10.017_bib51","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/0006-2952(68)90203-7","article-title":"Mode of spirolactone action: competitive inhibition of aldosterone binding to kidney mineralocorticoid receptors","volume":"17","author":"Fanestil","year":"1968","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib52","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2009.10.017_bib53","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/HYPERTENSIONAHA.107.105718","article-title":"Glucocorticoid-related signaling effects in vascular smooth muscle cells","volume":"51","author":"Molnar","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2009.10.017_bib54","first-page":"E1125","article-title":"Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone","volume":"263","author":"Gomez-Sanchez","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0960-0760(95)00235-9","article-title":"Mineralocorticoid receptors in the central nervous system","volume":"56","author":"Funder","year":"1996","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib56","first-page":"E649","article-title":"ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension","volume":"258","author":"Gomez-Sanchez","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0039-128X(94)00018-8","article-title":"Long-term treatment of mineralocorticoid excess syndromes","volume":"60","author":"Mantero","year":"1995","journal-title":"Steroids"},{"key":"10.1016\/j.bbadis.2009.10.017_bib58","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1046\/j.1523-1755.2000.00978.x","article-title":"Role of the 11\u03b2-hydroxysteroid dehydrogenase type 2 in blood pressure regulation","volume":"57","author":"Ferrari","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2009.10.017_bib59","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000049999","article-title":"Juvenile hypertension, the role of genetically altered steroid metabolism","volume":"55","author":"Ferrari","year":"2001","journal-title":"Horm. Res."},{"key":"10.1016\/j.bbadis.2009.10.017_bib60","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1210\/endo.137.12.8940344","article-title":"Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies","volume":"137","author":"Funder","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2009.10.017_bib61","first-page":"2263","article-title":"A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess","volume":"80","author":"Wilson","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib62","first-page":"3381","article-title":"The R337C mutation generates a high Km 11\u03b2-hydroxysteroid dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess","volume":"80","author":"Obeyesekere","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib63","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ng0895-394","article-title":"Human hypertension caused by mutations in the kidney isozyme of 11\u03b2-hydroxysteroid dehydrogenase","volume":"10","author":"Mune","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2009.10.017_bib64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0303-7207(96)03787-2","article-title":"Point mutations abolish 11\u03b2-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess","volume":"119","author":"Ferrari","year":"1996","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib65","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(96)90211-1","article-title":"Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11\u03b2-hydroxysteroid dehydrogenase type 2 gene","volume":"347","author":"Stewart","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2009.10.017_bib66","first-page":"4054","article-title":"A new compound heterozygous mutation in the 11\u03b2-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess","volume":"82","author":"Kitanaka","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib67","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3109\/10641969709083166","article-title":"Mutations in the 11\u03b2-hydroxysteroid dehydrogenase type II enzyme associated with hypertension and possibly stillbirth","volume":"19","author":"Krozowski","year":"1997","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.bbadis.2009.10.017_bib68","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/00004872-199715120-00005","article-title":"Apparent mineralocorticoid excess in a Brazilian kindred: hypertension in the heterozygote state","volume":"15","author":"Li","year":"1997","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bbadis.2009.10.017_bib69","first-page":"4391","article-title":"The codon 213 of the 11\u03b2-hydroxysteroid dehydrogenase type 2 gene is a hot spot for mutations in apparent mineralocorticoid excess","volume":"83","author":"Rogoff","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib70","doi-asserted-by":"crossref","first-page":"10200","DOI":"10.1073\/pnas.95.17.10200","article-title":"A genetic defect resulting in mild low-renin hypertension","volume":"95","author":"Wilson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbadis.2009.10.017_bib71","first-page":"2244","article-title":"Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess","volume":"83","author":"Dave-Sharma","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib72","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/301955","article-title":"Molecular basis for hypertension in the \u201ctype II variant\u201d of apparent mineralocorticoid excess","volume":"63","author":"Li","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2009.10.017_bib73","first-page":"1247","article-title":"A mutation in the cofactor-binding domain of 11\u03b2-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension","volume":"86","author":"Odermatt","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib74","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1210\/jc.2002-021909","article-title":"Two homozygous mutations in the 11\u03b2-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess","volume":"88","author":"Carvajal","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/01.HYP.0000083340.57063.35","article-title":"Late-onset apparent mineralocorticoid excess caused by novel compound heterozygous mutations in the HSD11B2 gene","volume":"42","author":"Lavery","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2009.10.017_bib76","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mce.2003.10.019","article-title":"Molecular basis for the apparent mineralocorticoid excess syndrome in the Oman population","volume":"217","author":"Quinkler","year":"2004","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib77","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1210\/jc.2003-031268","article-title":"In vitro expression studies of a novel mutation delta299 in a patient affected with apparent mineralocorticoid excess","volume":"89","author":"Lin-Su","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib78","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0039-128X(94)90080-9","article-title":"Apparent mineralocorticoid excess type II","volume":"59","author":"Mantero","year":"1994","journal-title":"Steroids"},{"key":"10.1016\/j.bbadis.2009.10.017_bib79","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.HYP.31.2.569","article-title":"Increased urinary free cortisol: a potential intermediate phenotype of essential hypertension","volume":"31","author":"Litchfield","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2009.10.017_bib80","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jep.2005.04.015","article-title":"A history of the therapeutic use of liquorice in Europe","volume":"99","author":"Fiore","year":"2005","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib81","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/gut.11.4.344","article-title":"Inhibition of peptic activity by carbenoxolone and glycyrrhetinic acid","volume":"11","author":"Henman","year":"1970","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2009.10.017_bib82","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0039-128X(93)90104-U","article-title":"Steroid hormones and hypertension: the cortisol-cortisone shuttle","volume":"58","author":"Stewart","year":"1993","journal-title":"Steroids"},{"key":"10.1016\/j.bbadis.2009.10.017_bib83","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1210\/jcem-70-6-1637","article-title":"The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers","volume":"70","author":"MacKenzie","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib84","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1210\/endo.132.6.8504732","article-title":"Licorice inhibits 11\u03b2-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action","volume":"132","author":"Whorwood","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2009.10.017_bib85","first-page":"251","article-title":"Liquorice: new insights into mineralocorticoid and glucocorticoid hypertension","volume":"76","author":"Morris","year":"1993","journal-title":"R I Med."},{"key":"10.1016\/j.bbadis.2009.10.017_bib86","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0024-3205(94)90042-6","article-title":"Effects of prolonged ingestion of graded doses of licorice by healthy volunteers","volume":"55","author":"Bernardi","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2009.10.017_bib87","first-page":"480","article-title":"Human kidney 11\u03b2-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform","volume":"79","author":"Stewart","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib88","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(87)91014-2","article-title":"Mineralocorticoid activity of liquorice: 11\u03b2-hydroxysteroid dehydrogenase deficiency comes of age","volume":"2","author":"Stewart","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2009.10.017_bib89","first-page":"221","article-title":"A new familial disorder characterized by hypokalemia and hypomagnesemia","volume":"79","author":"Gitelman","year":"1966","journal-title":"Trans. Assoc. Am. Physicians"},{"key":"10.1016\/j.bbadis.2009.10.017_bib90","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ng0696-183","article-title":"Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2","volume":"13","author":"Simon","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2009.10.017_bib91","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0022-3476(05)81173-4","article-title":"Gitelman syndrome and hypocalciuria","volume":"121","author":"Iwata","year":"1992","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbadis.2009.10.017_bib92","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/cs0630257","article-title":"Relation of arterial pressure with body sodium, body potassium and plasma potassium in essential hypertension","volume":"63","author":"Beretta-Piccoli","year":"1982","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bbadis.2009.10.017_bib93","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2265.1993.tb01778.x","article-title":"Deficient inactivation of cortisol by 11\u03b2-hydroxysteroid dehydrogenase in essential hypertension","volume":"39","author":"Walker","year":"1993","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib94","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.HYP.25.1.67","article-title":"Evidence of coexisting changes in 11\u03b2-hydroxysteroid dehydrogenase and 5 beta-reductase activity in subjects with untreated essential hypertension","volume":"25","author":"Soro","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2009.10.017_bib95","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/01.HYP.31.4.891","article-title":"Increased glucocorticoid activity in men with cardiovascular risk factors","volume":"31","author":"Walker","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2009.10.017_bib96","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ajh.2008.152","article-title":"Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients","volume":"21","author":"Henschkowski","year":"2008","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bbadis.2009.10.017_bib97","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2169\/internalmedicine.47.1165","article-title":"Spironolactone effective hypertension in the elderly due to 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) impairment: contributory role of determining serum cortisol\/cortisone ratio as a marker of 11beta-HSD2 activity","volume":"47","author":"Inada","year":"2008","journal-title":"Intern. Med."},{"key":"10.1016\/j.bbadis.2009.10.017_bib98","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/HJH.0b013e3282f2d35e","article-title":"Urinary cortisol to cortisone metabolites ratio in prednisone-treated and spontaneously hypertensive patients","volume":"26","author":"Olivieri","year":"2008","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bbadis.2009.10.017_bib99","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0039-128X(94)90022-1","article-title":"The activities of 5\u03b2-reductase and 11\u03b2-hydroxysteroid dehydrogenase in essential hypertension","volume":"59","author":"Iki","year":"1994","journal-title":"Steroids"},{"key":"10.1016\/j.bbadis.2009.10.017_bib100","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0895-7061(95)00021-G","article-title":"Cortisol metabolism in hypertensive patients who do and do not develop hypokalemia from diuretics","volume":"8","author":"Santini","year":"1995","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bbadis.2009.10.017_bib101","doi-asserted-by":"crossref","first-page":"I61","DOI":"10.1161\/01.HYP.17.1_Suppl.I61","article-title":"Salt sensitivity. Definition, conception, methodology, and long-term issues","volume":"17","author":"Sullivan","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2009.10.017_bib102","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.HYP.27.3.481","article-title":"Salt sensitivity of blood pressure in humans","volume":"27","author":"Weinberger","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2009.10.017_bib103","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/oxfordjournals.ndt.a027500","article-title":"Salt sensitivity as a phenotype for genetic studies of human hypertension","volume":"11","author":"Sharma","year":"1996","journal-title":"Nephrol. Dial Transplant."},{"key":"10.1016\/j.bbadis.2009.10.017_bib104","first-page":"3745","article-title":"Molecular basis of human salt-sensitivity: the role of the 11\u03b2-hydroxysteroid dehydrogenase type 2","volume":"84","author":"Lovati","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1677\/joe.0.1430505","article-title":"11\u03b2-hydroxysteroid dehydrogenase in the rat placenta: developmental changes and the effects of altered glucocorticoid exposure","volume":"143","author":"Burton","year":"1994","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib106","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/bmj.298.6673.564","article-title":"Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease","volume":"298","author":"Barker","year":"1989","journal-title":"Bmj"},{"key":"10.1016\/j.bbadis.2009.10.017_bib107","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s001250050573","article-title":"Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11\u03b2-hydroxysteroid dehydrogenase inhibitor carbenoxolone","volume":"39","author":"Lindsay","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2009.10.017_bib108","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0140-6736(93)90148-A","article-title":"Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension?","volume":"341","author":"Edwards","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2009.10.017_bib109","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0960-0760(95)00193-X","article-title":"Placental 11\u03b2-hydroxysteroid dehydrogenase and the programming of hypertension","volume":"55","author":"Seckl","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbadis.2009.10.017_bib110","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/01.HYP.28.3.478","article-title":"Genetic association of 11\u03b2-hydroxysteroid dehydrogenase type 2 (HSD11B2) flanking microsatellites with essential hypertension in blacks","volume":"28","author":"Watson","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2009.10.017_bib111","first-page":"1814","article-title":"A new polymorphic restriction site in the human 11\u03b2-hydroxysteroid dehydrogenase type 2 gene","volume":"83","author":"Smolenicka","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2009.10.017_bib112","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1046\/j.1523-1755.2000.00303.x","article-title":"Structural analysis of the 11\u03b2-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease","volume":"58","author":"Zaehner","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2009.10.017_bib113","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1291\/hypres.29.243","article-title":"Genetic variations of HSD11B2 in hypertensive patients and in the general population, six rare missense\/frameshift mutations","volume":"29","author":"Kamide","year":"2006","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bbadis.2009.10.017_bib114","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/00004872-199816110-00009","article-title":"Structural analysis and evaluation of the 11\u03b2-hydroxysteroid dehydrogenase type 2 (11\u03b2HSD2) gene in human essential hypertension","volume":"16","author":"Brand","year":"1998","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bbadis.2009.10.017_bib115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/01.HYP.36.2.187","article-title":"CA-Repeat polymorphism in intron 1 of HSD11B2: effects on gene expression and salt sensitivity","volume":"36","author":"Agarwal","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2009.10.017_bib116","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/jhh.2008.11","article-title":"Salt-sensitive men show reduced heart rate variability, lower norepinephrine and enhanced cortisol during mental stress","volume":"22","author":"Weber","year":"2008","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.bbadis.2009.10.017_bib117","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.amjhyper.2005.02.020","article-title":"Analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension","volume":"18","author":"Mariniello","year":"2005","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bbadis.2009.10.017_bib118","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1196\/annals.1448.005","article-title":"Hypertension and circulating mRNA for 11beta-hydroxysteroid dehydrogenase type II","volume":"1137","author":"Agalou","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2009.10.017_bib119","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.atherosclerosis.2007.11.029","article-title":"Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension","volume":"199","author":"Friso","year":"2008","journal-title":"Atherosclerosis"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443909002531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443909002531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T22:49:54Z","timestamp":1634165394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443909002531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":119,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0925443909002531"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2009.10.017","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}